
Applying AI to adverse event case processing: sharpening the impact of pharmacovigilance
For major pharma brands, for which pharmacovigilance (PV) has up to now primarily involved

For major pharma brands, for which pharmacovigilance (PV) has up to now primarily involved

What was the opportunity? Claudia Lehman, Boehringer Ingelheim (CL): We had already seen considerable

AUSTIN, Texas, May 1, 2025 (PR Newswire) —Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical

9 October 2024 The Royal Swedish Academy of Sciences has decided to award the
AI is an end-to-end solution for small molecule drug discovery combining AI and

“Deep Learning-Predicted Dihydroartemisinin Rescues Osteoporosis by Maintaining Mesenchymal Stem Cell Stemness through Activating Histone

“ChatGPT Chemistry Assistant for Text Mining and the Prediction of MOF Synthesis” Journal of